Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; ActivaPin, a bioabsorbable implant for upper and lower limb fractures; and ActivaScrew, an absorbable surgical implant that is used in fracture treatment, osteotomy, arthrodesis, and bone graft surgery. It also provides ActivaScrew Cannulated that offers a range of fully threaded and partially threaded cannulated screws for fixation of fractures and osteotomies; ActivaScrew Interference, a tool for multiple uses regarding bone fractures, osteotomies, arthrodesesm, and bone grafts; ActivaScrew Interference TCP, a biocomposite interference screw; and RemeOs Screw, a magnesium screw implants. The company was formerly known as BCI Bioabsorbable Concepts Oy. The company was incorporated in 1998 and is headquartered in Tampere, Finland.
Metrics to compare | BRETEC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBRETECPeersSector | |
---|---|---|---|---|
P/E Ratio | 0.0x | −3.6x | −0.5x | |
PEG Ratio | 0.00 | −0.20 | 0.00 | |
Price/Book | 0.0x | 3.3x | 2.6x | |
Price / LTM Sales | 0.0x | 4.5x | 3.3x | |
Upside (Analyst Target) | 0.0% | 58.8% | 43.4% | |
Fair Value Upside | Unlock | 7.0% | 7.1% | Unlock |